|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Federal funds sold | ||||||||||||||||||||
| Interest-bearing deposits with banks and other short-term investments | ||||||||||||||||||||
| Investment securities available-for-sale (amortized cost of $984,607 and $1,055,146, respectively, and allowance for credit losses of $0 and $0, respectively) | ||||||||||||||||||||
| Investment securities held-to-maturity, net of allowance for credit losses of $1,275 and $1,306, respectively (fair value of $820,530 and $820,382, respectively) | ||||||||||||||||||||
| Investment securities held-to-maturity, net of allowance for credit losses of $454 and $1,030, respectively (fair value of $730,994 and $774,947, respectively) | ||||||||||||||||||||
| Federal Reserve and Federal Home Loan Bank stock | ||||||||||||||||||||
| Loans held for sale, at lower of cost or fair value | ||||||||||||||||||||
| Loans held for investment, at amortized cost | ||||||||||||||||||||
| Less: Allowance for credit losses | ||||||||||||||||||||
| Loans held for investment, net of allowance | ||||||||||||||||||||
| Total Loans | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Right-of-use assets - operating leases | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Bank-owned life insurance | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Other real estate owned | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Liabilities and Shareholders’ Equity | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Deposits: | ||||||||||||||||||||
| Noninterest-bearing demand | ||||||||||||||||||||
| Interest-bearing transaction | ||||||||||||||||||||
| Savings and money market | ||||||||||||||||||||
| Time deposits | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Customer repurchase agreements | ||||||||||||||||||||
| Borrowings | ||||||||||||||||||||
| Other short-term borrowings | ||||||||||||||||||||
| Long-term borrowings | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Reserve for unfunded commitments | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Shareholders’ Equity | ||||||||||||||||||||
| Common stock, par value 0.01 per share; shares authorized 100,000,000, shares issued and outstanding 30,490,409 and 30,359,632, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Total Shareholders’ Equity | ||||||||||||||||||||
| Total Liabilities and Shareholders’ Equity | ||||||||||||||||||||
Loading...
